Nanomedicine News

RSS

Fine Tuning Nanoparticles for Biotargeting Applications

Researchers from Abo Akademi University and the University of Turku in Finland have discovered that the stability of functionalised nanoparticles is crucially dependent on all functional groups present on the surface.

From Malvern Panalytical 9 Jun 2009

Provider of DNA-Based Security Solutions Validates Use of Proprietary SigNature DNA into Laminates

Applied DNA Sciences, Inc. (OTCBB: APDN), announced today that in collaboration with a world leader in security laminated materials, it has validated its proprietary SigNature® DNA into laminates typically used in travel documents, credit cards, drivers licenses and other government issued identification cards.

9 Jun 2009

Six Scientists from University of Queensland Receives Smart Future Fellowships

Six scientists from The University of Queensland, one of Australia's premier learning and research institutions, have received Smart Future Fellowships to help further their research into areas such as disease detect...

9 Jun 2009

Veeco Co-Sponsor MBE Innovator Award in Conjunction with NAMBE Organization

Veeco Instruments Inc., will again co-sponsor the MBE Innovator Award in 2009 in conjunction with the North American Molecular Beam Epitaxy (NAMBE) organization.

From Veeco 9 Jun 2009

Financing Allows NanoString to Accelerate Commercialization of nCounter Analysis System

NanoString Technologies, a life sciences tool company that is commercializing a novel and uniquely user-friendly technology for characterizing and quantifying expression profiles in complex biological samples, announced today that it has closed a $30 million Series C equity financing.

From Nanostring Technologies 9 Jun 2009

Research Groups Develop New Tools to Control Cells

This will lead, for example, to new ways of growing stem cells, or manipulating cells in the organism and in bioreactor systems. These key technologies will ultimately contribute to the development of new therapies for many degenerative diseases that affect muscle, the retina or the central nervous system.

8 Jun 2009

Improved Performance of DiLA2 siRNA Delivery Platform With Proprietary Peptide Nanoparticles

MDRNA, Inc. (NASDAQ: MRNA), a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi), announced today in vivo data from a bladder cancer model demo...

8 Jun 2009

Aposense and GSK Announces Collaboration

Aposense Ltd., a molecular imaging and drug development company, leading the translation of the science of apoptosis (programmed cell death) into clinical practice, today announced a collaboration with GlaxoSmithKline (G...

8 Jun 2009

Researchers Use Synchrotron's Infrared Microscope to Identify Tissue Afflicted with Barrett's Esophagus

Canadian Light Source (CLS) staff scientist Luca Quaroni and Dr. Alan Casson, Head of the Department of Surgery at the University of Saskatchewan (U of S) used the synchrotron's infrared microscope to identify tissue afflicted with a condition known as Barrett's Esophagus from chemical fingerprints associated with the disease.

8 Jun 2009

Improving the Process of Identifying New Cancer Biomarkers

International experts in cancer research and proteomics are gathering in Dublin this week to discuss how the convergence of these research areas can improve the process of identifying new cancer biomarkers. This flagshi...

8 Jun 2009